<DOC>
	<DOCNO>NCT00833469</DOCNO>
	<brief_summary>The purpose study determine whether woman postpartum major depressive disorder ( MDD ) experience significant decrease depressive symptom baseline eight-week treatment intervention escitalopram ( Lexapro ) . Also , determine whether woman postpartum MDD experience significant decrease anxiety symptom .</brief_summary>
	<brief_title>Escitalopram ( Lexapro ) Treatment Postpartum Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression , Postpartum</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Women age 18 45 year old Subjects must meet criterion major depressive episode symptom develop within three month live childbirth Subjects must present within six month childbirth MADRS score &gt; 15 BAI score &gt; 10 Subjects able treated outpatient basis Subjects able provide write informed consent Subjects take psychotropic medication , include antidepressant antianxiety medication , within past two week ( exception nonbenzodiazepine medication use sleep , include trazodone , zolpidem , eszopiclone , etc ) Suicidal ideation active plan intent , determine investigator Presence psychotic symptom homicidal ideation History mania hypomania Pregnant breastfeeding Presence chronic depression dysthymia , chronic treatment resistant anxiety disorder , determine investigator Active alcohol/substance abuse currently within past year Abnormal TSH , severe anemia , uncontrolled hypertension</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>woman</keyword>
	<keyword>postpartum depression</keyword>
	<keyword>anxiety</keyword>
</DOC>